inHEART provides a digital twin of the patient’s heart from pre-operative medical images that contains key information to better plan and guide cardiac interventions. Results have shown to reduce procedure time from 5+ hours to 2- hours by replacing complex and tedious intra-operative electrical measurements with pre-operative image analysis. Moreover, it increases its success rate from 60% to more than 75%. inHEART technology is CE marked and registered to the FDA. Provided as a cloud-based service in more than 50 centres across Europe and US, it has benefited to more than 3,000 patients.

Funding: Looking for Series A ($12m)